Home / 2014 / March (page 8)

Monthly Archives: March 2014

An A1c of 5.7% Indicates Greater Heart Risk

Researchers found participants with normal glucose tolerance but A1C rates between 5.7% and 6.4% had increased intima-media thickness and augmentation and augmentation index, suggesting that an A1C threshold of 5.7% may help better identify patients at greater cardiovascular risk. "These results suggest that an HbA1c cutoff of 5.7% is more …

Read More »

Albiglutide (FDA Application Pending) Has Greater Tolerability, Comparable A1c Reductions, But Less Weight Loss

Research showed type 2 diabetes patients who took once-weekly albiglutide attained significant reductions in A1C, comparable with those who were on once-daily liraglutide. "The data indicate that albiglutide is a reasonable alternative to other glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of diabetes. Researchers said that, "It has good …

Read More »